Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The need for quality control in the developing countries

Developments in Biological Standardization

|January 1, 1978

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Precautions against B virus infection.

British medical journal·2010

Same author

Licensed vaccines.

Reviews of infectious diseases·1985

Same author

The standardization of vaccines: a discussion.

Reviews of infectious diseases·1984

Same author

Stability of further-attenuated measles vaccines.

Reviews of infectious diseases·1983

Same author

Measles vaccines: discussion.

Reviews of infectious diseases·1983

Same author

Stability of human diploid-cell-strain rabies vaccine at high ambient temperatures.

Lancet (London, England)·1983

Same journal

International challenges and public policy issues.

Developments in biological standardization·2000

Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000

Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000

Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000

Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000

Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000

See all related articles

Establishing vaccine quality control in developing nations is crucial for immunization programs. This ensures vaccine efficacy, monitors cold chain integrity, and assesses local antibody responses, improving public health outcomes.

Area of Science:

Public Health
Immunology
Pharmaceutical Sciences

Background:

Developing countries require enhanced quality control for vaccines used in national immunization programs.
Existing quality control measures may be insufficient to guarantee vaccine efficacy and safety.

Purpose of the Study:

To highlight the necessity of robust vaccine quality control in developing nations.
To explore the multifaceted role of a quality control facility in ensuring vaccine effectiveness.

Main Methods:

Discusses the establishment of a dedicated quality control facility.
Proposes monitoring vaccine release, cold chain efficacy, and local antibody responses.
Considers the economic feasibility of importing bulk vaccines for local processing.

Related Experiment Videos

Main Results:

A quality control facility can verify vaccine quality at release and monitor cold chain performance.
It enables measurement of antibody responses in the local pediatric population.
Local dilution, blending, and filling of imported bulk vaccines is economically viable.

Conclusions:

Quality control infrastructure should precede local vaccine manufacturing or processing.
Implementing comprehensive quality control is essential for successful immunization programs in developing countries.
Economic analysis suggests local processing of imported bulk vaccines is a feasible strategy.